by Jody Ranck | April 12, 2021
Digital Twins 101
Digital twins provide more dynamic models than conventional simulations and will provide valuable tools for precision medicine. Learn more in this deep dive article.
Tag Archive: FDA
by Jody Ranck | April 12, 2021
Digital twins provide more dynamic models than conventional simulations and will provide valuable tools for precision medicine. Learn more in this deep dive article.
by Chilmark Team | December 18, 2020
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]
by Jody Ranck | October 15, 2020
While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare.
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]
by Chilmark Team | December 10, 2018
The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define […]
by Chilmark Team | November 29, 2018
As is our custom here, we like to look back on our predictions for the closing year and see just […]
by Brian Edwards | December 19, 2017
Key Takeaways: The FDA has released long-anticipated draft guidance on how they intend to regulate clinical decision support products. For […]
by Naveen Rao | July 27, 2015
Progress? Healthcare organizations (HCOs) are acknowledging the need for next generation tools to realize the promise of newer models of […]
Alex Lennox-Miller · 3 months ago
Jody Ranck · 3 months ago
Alex Lennox-Miller · 2 months ago